Mikhail Eydelman
Compliance Officer chez VAXCYTE, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Mikhail Eydelman is currently working as the Secretary, Chief Compliance Officer & Senior VP at Vaxcyte, Inc. Prior to his current position, he worked as the Secretary & General Counsel at Sagent Pharmaceuticals, Inc. from 2017 to 2022.
Mr. Eydelman completed his undergraduate degree at Brandeis University and his graduate degree at New York University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXCYTE, INC.
0,03% | 01/04/2024 | 30 597 ( 0,03% ) | 2 M $ | 31/03/2024 |
Postes actifs de Mikhail Eydelman
| Sociétés | Poste | Début |
|---|---|---|
| VAXCYTE, INC. | Compliance Officer | 01/04/2022 |
Anciens postes connus de Mikhail Eydelman
| Sociétés | Poste | Fin |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | General Counsel | 01/04/2022 |
Formation de Mikhail Eydelman
| Brandeis University | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
